Publication:
Future directions for ureteral stent technology: from bench to the market

Thumbnail Image

Organizational Units

Program

KU-Authors

KU Authors

Co-Authors

Domingues, Beatriz
Pacheco, Margarida
de la Cruz, Julia E.
Carmagnola, Irene
Teixeira-Santos, Rita
Laurenti, Marco
Bohinc, Klemen
Moutinho, Fabiola
Silva, Joana M.
Aroso, Ivo M.

Advisor

Publication Date

2022

Language

English

Type

Review

Journal Title

Journal ISSN

Volume Title

Abstract

Ureteral stents are broadly used for the treatment of a wide range of pathologies, with different complexities and characteristics. Despite being efficient, the morbidity associated with stents, such as bacterial infection and pain, limits their therapeutic action and often represents an increase in healthcare costs. As no single solution fits all problems, there is still a need to improve these medical devices. Throughout this review, the most recent innovations are outlined and suggestions regarding future directions for ureteral stent technology are formulated with respect to materials, coatings, and designs of these devices. As highlighted here, during the process of passing these innovations to the growing market of ureteral stents, one of the biggest challenges is to increase the predictive value of the in vitro assays and, consequently, reduce the number of in vivo tests needed. Thus, recommendations concerning in vitro standard testing of these devices are provided, with focus on medium, flow conditions, and microbiological parameters. Additionally, the reader is also presented with insights about a crucial but rarely discussed topic, the bureaucratic part of the bench to market process, particularly the product certification legislation in Europe.

Description

Source:

Advanced Therapeutics

Publisher:

Wiley

Keywords:

Subject

Pharmacology and Pharmacy

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note

3

Views

0

Downloads

View PlumX Details